Retro Biosciences: Funding, Investors & Team (Oct 2026)
Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.
Retro Biosciences has raised $180M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2026.
Retro Biosciences Company Profile and Key Stats
Latest funding round on record: May 2026.
Retro Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Retro Biosciences raised $180M in an Undisclosed announced in Apr 2022.
4.1 years later, an undisclosed round was announced in May 2026 with no disclosed amount.
Retro Biosciences Founders and Leadership Team
Contact details for the Retro Biosciences team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Retro Biosciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Retro Biosciences in Biotechnology and San Francisco
Companies Similar to Retro Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Retro Biosciences Funding FAQs
What does Retro Biosciences do?
Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.
How much funding has Retro Biosciences raised?
Retro Biosciences has raised $180M across 2 rounds on record.
When did Retro Biosciences last raise funding?
Retro Biosciences' most recent funding round on record was announced in May 2026. The amount was not disclosed.
Who founded Retro Biosciences?
FundedIQ lists "joe Betts (Founder) at Retro Biosciences.
Who is the CEO of Retro Biosciences?
Joe Betts-Lacroix is listed as CEO at Retro Biosciences.
Where is Retro Biosciences headquartered?
Retro Biosciences is based in San Francisco, California, United States.
How many employees does Retro Biosciences have?
Retro Biosciences is in the 11-50 employee band.
About FundedIQ's Retro Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Retro Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.